Fasudil inhibits the proliferation and contractility and induces cell cycle arrest and apoptosis of human endometriotic stromal cells: A promising agent for the treatment of endometriosis

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 12, 2011, Pages

  Tsuno, Akitoshi ^a   Nasu, Kaei ^a   Kawano, Yukie ^a   Yuge, Akitoshi ^a   Li, Haili ^a   Abe, Wakana ^a   Narahara, Hisashi ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FASUDIL; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE; PROTEIN ROCK I; PROTEIN ROCK II; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DENSITY; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; ENDOMETRIOSIS; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT RESPONSE; UPREGULATION;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ADULT; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; OVARIAN DISEASES; PROTEIN KINASE INHIBITORS; STROMAL CELLS;

EID: 83155177124     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1503     Document Type: Article

References (39)

1. Olive DL, Schwartz LB 1993 Endometriosis. N Engl J Med 328: 1759-1769
2. Nisolle M, Donnez J 1997 Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 68:585-596 (Pubitemid 27454315)
3. Matsuzaki S, Canis M, Darcha C, Dechelotte P, Pouly JL, Bruhat MA1990 Fibrogenesis in peritoneal endometriosis. Gynecol Obstet Invest 47:197-199
4. Anaf V, Simon P, Fayt I, Noel J-C 2000 Smooth muscles are frequent components of endometriotic lesions. Hum Reprod 15:767-771 (Pubitemid 30192720)
5. Stovall DW, Anners JA, Halme J 1992 Immunohistochemical detection of type I, III, and IV collagen in endometriotic implants. Fertil Steril 57:984-989
6. Yuge A, Nasu K, Matsumoto H, Nishida M, Narahara H 2007 Collagen gel contractility is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis-associated fibrosis. Hum Reprod 22:938-944
7. Nasu K, Yuge A, Tsuno A, Narahara H 2009 Simvastatin inhibits the proliferation and the contractility of human endometriotic stromal cells: a promising agent for the treatment of endometriosis. Fertil Steril 92:2097-2099
8. Tsuno A, Nasu K, Yuge A, Matsumoto H, Nishida M, Narahara H 2009 Decidualization attenuates the contractility of eutopic and ectopic endometrial stromal cells: implications for hormone therapy of endometriosis.J Clin Endocrinol Metab 94:2516-2523
9. Nasu K, Tsuno A, Hirao M, Kobayashi H, Yuge A, Narahara H 2010 Heparin is a promising agent for the treatment of endometriosis- associated fibrosis. Fertil Steril 94:46-51
10. Nasu K, Yuge A, Tsuno A, Narahara H 2010 Mevalonate-Ras homology (Rho)/Rho-associated coiled-coil-forming protein kinase (ROCK)-mediated signaling pathway as a therapeutic target for the treatment of endometriosis-associated fibrosis. Curr Signal Transduct Ther 5:141-148
11. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S 1997 Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389:990-904
12. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A 2002 Suppression of coronary artery spasm by the ROCK inhibitor fasudil in patients with vasospastic angina. Circulation 105:1545-1547
13. Shibuya M, Hirai S, Seto M, Satoh S, Ohtomo E 2005 Effects of Fasudil in acute ischemic stroke: results of a prospective placebocontrolled double-blind trial. J Neurol Sci 238:31-39 (Pubitemid 41560951)
14. Asano T, Ikegaki I, Satoh S, Mochizuki D, Hidaka H, Suzuki Y, Shibuya M, Sugita K 1991 Blockade of intracellular actions of calcium may protect against ischaemic damage to the gerbil brain. Br J Pharmacol 103:1935-1938
15. Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, Nagata I, Kikuchi H, Takemae T, Hidaka H, Nakashima M 1992 Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double- blind trial. J Neurosurg 76:571-577
16. Asano T, Suzuki T, Tsuchiya M, Satoh S, Ikegaki I, Shibuya M, Suzuki Y, Hidaka H 1989 Vasodilator actions of HA 1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase. Br J Pharmacol 98:1091-1100 (Pubitemid 20011061)
17. Seto M, Sasaki Y, Hidaka H, Sasaki Y 1991 Effects of HA1077, a protein kinase inhibitor, on myosin phosphorylation and tension in smooth muscle. Eur J Pharmacol 195:267-272
18. Nishida M, Nasu K, Fukuda J, Kawano Y, Narahara H, Miyakawa I 2004 Down-regulation of interleukin-1 receptor type 1 expression causes the dysregulated expression of CXC chemokines in endometriotic stromal cells: a possible mechanism for the altered immunological functions in endometriosis. J Clin Endocrinol Metab 89:5094-5100 (Pubitemid 39391454)
19. Nishida M, Nasu K, Ueda T, Fukuda J, Takai N, Miyakawa I 2005 Endometriotic cells are resistant to interferon-γ-induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis. Mol Hum Reprod 11:29-34 (Pubitemid 40331000)
20. Matsumoto H, Nasu K, Nishida M, Ito H, Bing S, Miyakawa I 2005 Regulation of proliferation, motility, and contractility of human endometrial stromal cells by platelet-derived growth factor. J Clin Endocrinol Metab 90:3560-3567 (Pubitemid 41014327)
21. Boyce-Rustay JM, Simler GH, McGaraughty S, Chu KL, Wensink EJ, Vasudevan A, Honore P 2010 Characterization of fasudil in preclinical models of pain. J Pain 11:941-949
22. Lee TL, Lin YC, Mochitate K, Grinnell F 1993 Stress-relaxation of fibroblasts in collagen matrices triggers ectocytosis of plasma membrane vesicles containing actin, annexins II and VI, and β1 integrin receptors. J Cell Sci 105:167-177 (Pubitemid 23187556)
23. Amano M, Chihara K, Kimura K, Fukata Y, Nakamura N, Matsuura Y, Kaibuchi K 1997 Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 275:1308-1311 (Pubitemid 27114159)
24. Van Aelst L, D'Souza-Schorey C 1997 Rho GTPases and signaling networks. Genes Dev 11:2295-2322 (Pubitemid 27408529)
25. Ravanti L, Heino J, López-Otín C, Kähäri VM 1999 Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J Biol Chem 274:2446-2455
26. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, Narumiya S 2000 Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 57:976-983 (Pubitemid 30253382)
27. Etienne-Manneville S, Hall A 2002 Rho GTPases in cell biology. Nature 420:629-635 (Pubitemid 36764489)
28. Hall A 2005 Rho GTPases and the control of cell behaviour. Biochem Soc Trans 33:891-895 (Pubitemid 41659073)
29. Sumi T, Matsumoto K, Nakamura T 2001 Specific activation LIM kinase 2 via phosphorylation of threonine 505 by ROCK, a Rhodependent protein kinase. J Biol Chem 276:670-676 (Pubitemid 32050364)
30. Vahebi S, Kobayashi T, Warren CM, de Tombe PP, Solaro RJ 2005 Functional effects of rho-kinase-dependent phosphorylation of specific sites on cardiac troponin. Circ Res 96:740-747 (Pubitemid 40559513)
31. Yamamoto M, Ramirez SH, Sato S, Kiyota T, Cerny RL, Kaibuchi K, Persidsky Y, Ikezu T 2008 Phosphorylation of claudin-5 and occluding by rho kinase in brain endothelial cells. Am J Pathol 172: 521-533 (Pubitemid 351282037)
32. Goldstein JL, Brown MS 1990 Regulation of the mevalonate pathway. Nature 343:425-430
33. Löhn M, Plettenburg O, Ivashchenko Y, Kannt A, Hofmeister A, Kadereit D, Schaefer M, Linz W, Kohlmann M, Herbert JM, Janiak P, O'Connor SE, Ruetten H 2009 Pharmacological characterization of SAR407899, a novel Rho-kinase inhibitor. Hypertension 54:676-683
34. Doe C, Bentley R, Behm DJ, Lafferty R, Stavenger R, Jung D, Bamford M, Panchal T, Grygielko E, Wright LL, Smith GK, Chen Z, Webb C, Khandekar S, Yi T, Kirkpatrick R, Dul E, Jolivette L, Marino Jr JP, Willette R, Lee D, Hu E 2007 Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities. J Pharmacol Exp Ther 320:89-98 (Pubitemid 46025723)
35. Feng Y, Cameron MD, Frackowiak B, Griffin E, Lin L, Ruiz C, Schröter T, LoGrasso P 2007 Structure-activity relationships, and drug metabolism and pharmacokinetic properties for indazole piperazine and indazole piperidine inhibitors of ROCK-II. Bioorg Med Chem Lett 17:2355-2360 (Pubitemid 46484293)
36. Boerma M, Fu Q, Wang J, Loose DS, Bartolozzi A, Ellis JL, McGonigle S, Paradise E, Sweetnam P, Fink LM, Vozenin-Brotons MC, Hauer-Jensen M 2008 Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatin. Blood Coagul Fibrinolysis 19:709-718
37. Logé C, Wallez V, Scalbert E, Cario-Tourmaniantz C, Loirand G, Pacaud P, Lesieur D 2002 Rho-kinase inhibitors: pharmacomodulations on the lead compound Y-32885. J Enzyme Inhib Med Chem 17:381-390 (Pubitemid 36113728)
38. Vicari RM, Chaitman B, Keefe D, Smith WB, Chrysant SG, Tonkon MJ, Bittar N, Weiss RJ, Morales-Ballejo H, Thadani U; Fasudil Study Group 2005 Efficacy and safety of fasudil in patients with stable angina:Adoubleblind, placebo-controlled, phase 2 trial. J Am Coll Cardiol 46:1803-1811
39. Hara M, Takayasu M, Watanabe K, Noda A, Takagi T, Suzuki Y, Yoshida J 2000 Protein kinase inhibition by fasudil hydrochloride promotes neurological recovery after spinal cord injury in rats. J Neurosurg 93(1 Suppl):94-101 (Pubitemid 30457388)